Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)
- 31 May 2004
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 44 (2) , 251-259
- https://doi.org/10.1016/j.lungcan.2003.10.011
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- MesotheliomaPublished by Springer Nature ,2003
- Edatrexate (10‐ethyl‐deaza‐aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesotheliomaCancer, 1999
- Factors Predictive of Survival Among 337 Patients With Mesothelioma Treated Between 1984 and 1994 by the Cancer and Leukemia Group BChest, 1998
- Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesotheliomaAnnals of Oncology, 1998
- Dihydro-5-azacytidine in malignant mesotheliomaCancer, 1997
- Chemotherapy in malignant pleural mesothelioma. A review.Journal of Clinical Oncology, 1996
- High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II studyBritish Journal of Cancer, 1992
- Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.Journal of Clinical Oncology, 1988
- High-dose methotrexate with citrovorum factor and vincristine in the treatment of malignant mesotheliomaCancer, 1982
- Diffuse Malignant MesotheliomaAnnals of Internal Medicine, 1982